发布求助
文献互助 智能选刊 最新文献

Adverse Drug Reaction Bulletin最新文献

筛选
英文 中文
Drug interactions with herbal medicines: mechanisms and implications 药物与草药的相互作用:机制和影响
Adverse Drug Reaction Bulletin Pub Date : 2021-02-01 DOI: 10.1097/FAD.0000000000000053
P. Routledge, R. Bracchi, F. Woods
{"title":"Drug interactions with herbal medicines: mechanisms and implications","authors":"P. Routledge, R. Bracchi, F. Woods","doi":"10.1097/FAD.0000000000000053","DOIUrl":"https://doi.org/10.1097/FAD.0000000000000053","url":null,"abstract":"","PeriodicalId":39261,"journal":{"name":"Adverse Drug Reaction Bulletin","volume":"326 1","pages":"1263-1266"},"PeriodicalIF":0.0,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"61684706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
SUBJECT AND DRUG INDEXES TO ADVERSE DRUG REACTION BULLETIN: Nos 320–325 February 2020 – December 2020 不良药物反应公告的受试者和药物指标：编号320–325 2020年2月至2020年12月
Adverse Drug Reaction Bulletin Pub Date : 2020-12-01 DOI: 10.1097/00012995-199708000-00002
{"title":"SUBJECT AND DRUG INDEXES TO ADVERSE DRUG REACTION BULLETIN: Nos 320–325 February 2020 – December 2020","authors":"","doi":"10.1097/00012995-199708000-00002","DOIUrl":"https://doi.org/10.1097/00012995-199708000-00002","url":null,"abstract":"","PeriodicalId":39261,"journal":{"name":"Adverse Drug Reaction Bulletin","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/00012995-199708000-00002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47499216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bisphosphonate use and the risk of atypical fractures 双膦酸盐的使用与非典型骨折的风险
Adverse Drug Reaction Bulletin Pub Date : 2020-12-01 DOI: 10.1097/FAD.0000000000000052
Debdipta Bose, N. Gogtay
{"title":"Bisphosphonate use and the risk of atypical fractures","authors":"Debdipta Bose, N. Gogtay","doi":"10.1097/FAD.0000000000000052","DOIUrl":"https://doi.org/10.1097/FAD.0000000000000052","url":null,"abstract":"Bisphosphonates (BPs) have been in the market for the past 40 years and proven beneficial especially for patients with osteoporosis and prevention of hypercalcemic in malignancy. However, their long-term use raises safety concerns like Atypical femoral fracture and Osteonecrosis of the Jaw whose pathophysiology still remains unclear. Atypical femoral fracture is more commonly seen among BP users with at least six years of therapy and concomitant use of drugs such as glucocorticoids. The most common treatment for atypical femoral fracture is to withdraw the therapy with monitoring of bone resorption markers but the definitive treatment is intramedullary nail fixation where necessary. Hence, physicians must be vigilant to rarer and long-term BP-reported adverse effects and understand the evidence around the use of these drugs including drug free holidays. A structured benefit-risk assessment should be made for every individual patient including communicating the risk of these rare side effects.","PeriodicalId":39261,"journal":{"name":"Adverse Drug Reaction Bulletin","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47970050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse drug reactions: five historical scandals 药物不良反应:五个历史丑闻
Adverse Drug Reaction Bulletin Pub Date : 2020-10-01 DOI: 10.1097/FAD.0000000000000050
H. Horwitz, D. Gotfredsen, T. Christoffersen
{"title":"Adverse drug reactions: five historical scandals","authors":"H. Horwitz, D. Gotfredsen, T. Christoffersen","doi":"10.1097/FAD.0000000000000050","DOIUrl":"https://doi.org/10.1097/FAD.0000000000000050","url":null,"abstract":"Henrik Horwitz, Ditte Resendal a Gotfredsen & Thea Christoffersen Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark Correspondence to Henrik Horwitz, MD, PhD, associate professor, Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark. Tel.: +4529464288. E-mail: henrik_horwitz@hotmail.com and henrik.horwitz@regionh.dk","PeriodicalId":39261,"journal":{"name":"Adverse Drug Reaction Bulletin","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/FAD.0000000000000050","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48574625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Drugs during lactation 哺乳期药物
Adverse Drug Reaction Bulletin Pub Date : 2020-08-01 DOI: 10.1097/FAD.0000000000000049
J. Andersen, T. Futtrup
{"title":"Drugs during lactation","authors":"J. Andersen, T. Futtrup","doi":"10.1097/FAD.0000000000000049","DOIUrl":"https://doi.org/10.1097/FAD.0000000000000049","url":null,"abstract":"Jon T. Andersen & Tina Bergmann Futtrup Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg, in concentration between the drug level in plasma and that in breast milk. The higher the concentration of free drug molecules in plasma, the higher the concentration in the breast milk. In the first days after birth the August 2020 No. 323 Founded in 1966 by Professor D M Davies, FRCP, FRCP Ed ISSN 0044–6394","PeriodicalId":39261,"journal":{"name":"Adverse Drug Reaction Bulletin","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/FAD.0000000000000049","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41447781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-induced priapism 药物引起的阴茎持续勃起症
Adverse Drug Reaction Bulletin Pub Date : 2020-06-01 DOI: 10.1097/FAD.0000000000000048
M. Pucci, Penelope Roussak, D. Pang, M. Darrad
{"title":"Drug-induced priapism","authors":"M. Pucci, Penelope Roussak, D. Pang, M. Darrad","doi":"10.1097/FAD.0000000000000048","DOIUrl":"https://doi.org/10.1097/FAD.0000000000000048","url":null,"abstract":"","PeriodicalId":39261,"journal":{"name":"Adverse Drug Reaction Bulletin","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/FAD.0000000000000048","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43736796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Drugs in pregnancy 孕期药物
Adverse Drug Reaction Bulletin Pub Date : 2020-04-01 DOI: 10.1097/fad.0000000000000047
J. Andersen, T. Futtrup
{"title":"Drugs in pregnancy","authors":"J. Andersen, T. Futtrup","doi":"10.1097/fad.0000000000000047","DOIUrl":"https://doi.org/10.1097/fad.0000000000000047","url":null,"abstract":"","PeriodicalId":39261,"journal":{"name":"Adverse Drug Reaction Bulletin","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/fad.0000000000000047","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42607827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
SUBJECT AND DRUG INDEXES TO ADVERSE DRUG REACTION BULLETIN: Nos 314-319 February 2019 - December 2019 不良药物反应公告的受试者和药物指标：编号：314-319 2019年2月-2019年12月
Adverse Drug Reaction Bulletin Pub Date : 2020-02-01 DOI: 10.1097/fad.0000000000000046
{"title":"SUBJECT AND DRUG INDEXES TO ADVERSE DRUG REACTION BULLETIN: Nos 314-319 February 2019 - December 2019","authors":"","doi":"10.1097/fad.0000000000000046","DOIUrl":"https://doi.org/10.1097/fad.0000000000000046","url":null,"abstract":"","PeriodicalId":39261,"journal":{"name":"Adverse Drug Reaction Bulletin","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/fad.0000000000000046","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46314489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Apixaban-induced leukocytoclastic vasculitis 阿哌沙班诱导的白细胞破裂性血管炎
Adverse Drug Reaction Bulletin Pub Date : 2020-02-01 DOI: 10.1097/FAD.0000000000000045
P. Esbech, J. Schmidt, L. K. Andersen, P. Damkier
{"title":"Apixaban-induced leukocytoclastic vasculitis","authors":"P. Esbech, J. Schmidt, L. K. Andersen, P. Damkier","doi":"10.1097/FAD.0000000000000045","DOIUrl":"https://doi.org/10.1097/FAD.0000000000000045","url":null,"abstract":"Introduction: Drug-induced vasculitis is a rare adverse drug reaction and the potential to induce such a reaction is often established postmarketing. Leukocytoclastic vasculitis a subtype of drug-induced vasculitis often presents itself with palpable purpuric lesions, and often within weeks of initial administration. Case-description: We present a 62-year-old male who presented with leukocytoclastic vasculitis within the first 8 days of apixaban-initiation. Symptoms improved upon discontinuation and resolved after several months of prednisone therapy. Literature review: We conducted a search on PubMed, which yielded 10 reports of leukocytoclastic vasculitis induced by NOACs, of these 10 only 1 had been caused by apixaban, 4 caused by dabigatran and 5 had been caused by rivaroxaban. Of these cases, one presented with leukocytoclastic vasculitis induced by both rivaroxaban and dabigatran, and one case presented successful switch from apixaban to rivaroxaban. Conclusion: Apixaban-induced leukocytoclastic vasculitis is a rare but serious and important adverse reaction.","PeriodicalId":39261,"journal":{"name":"Adverse Drug Reaction Bulletin","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/FAD.0000000000000045","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41379989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Cytokine release syndrome: a primer for generalists 细胞因子释放综合征：多面手的引物
Adverse Drug Reaction Bulletin Pub Date : 2019-12-01 DOI: 10.1097/FAD.0000000000000044
Tiago Soares, H. Fok
{"title":"Cytokine release syndrome: a primer for generalists","authors":"Tiago Soares, H. Fok","doi":"10.1097/FAD.0000000000000044","DOIUrl":"https://doi.org/10.1097/FAD.0000000000000044","url":null,"abstract":"Cytokine release syndrome (CRS) is an adverse drug reaction that is poorly understood but is likely to be increasingly common as more immunotherapeutics are being developed and licensed, principally in the treatment of cancer. Early recognition and aggressive treatment of this potentially rapidly fatal systemic inflammatory response syndrome (SIRS) is the key to a better outcome for this adverse drug reaction.","PeriodicalId":39261,"journal":{"name":"Adverse Drug Reaction Bulletin","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/FAD.0000000000000044","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42272771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信